TA
Tanveer Ahmad
Cellogen Therapeutics Pvt Ltd, Jamia Millia Islamia, National Institutes of Health, CSIR-IGIB
0000-0002-8384-5273
Employment
-
Cellogen Therapeutics Pvt Ltd Director2026 - 2035
-
Jamia Millia Islamia Assistant Professor2017 - 2026
Education
-
National Institutes of Health Postdoctorate2013 - 2017
-
CSIR-IGIB Phd2007 - 2013
Projects & Funding
Projects & funding information is unavailable.
Publications (46)
- AI-guided CAR designs and targeted pathway modulation to enhance multi-antigen CAR T cell durability and overcome antigen escape. Save
- Bioengineering the metabolic network of CAR T cells with GLP-1 and Urolithin A increases persistence and long-term anti-tumor activity Save
- CRISPR-Cas12a based detection of EGFR gene mutation in cell free DNA for early diagnosis of Non-Small Cell Lung Cancer (NSCLC) Save
- High-resolution AI image dataset for diagnosing oral submucous fibrosis and squamous cell carcinoma Save
- Dual Detection of Hepatitis B and C Viruses Using CRISPR‐Cas Systems and Lateral Flow Assay Save
- MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosis. Save
- MiR-326 mediated overexpression of NFIB offsets TGF-β induced Epithelial to Mesenchymal Transition and reverses lung fibrosis Save
- Obesity impairs cardiolipin-dependent mitophagy and therapeutic intercellular mitochondrial transfer ability of mesenchymal stem cells Save
- Transcytosis and trans-synaptic retention by postsynaptic ErbB4 underlie axonal accumulation of NRG3 Save
- Altered mitochondrial calcium handling and cell death by necroptosis: An emerging paradigm Save